slotkoers
Korea S.E.
00:00:00 20-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
9.560
KRW
|
-0,21%
|
|
+0,63%
|
+17,59%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
187.287
|
248.532
|
180.186
|
146.101
|
144.326
|
Bedrijfswaarde
1 |
140.920
|
233.063
|
200.287
|
174.992
|
178.424
|
K/w-verhouding
|
26,3
x
|
163
x
|
26,9
x
|
18,3
x
|
21,4
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,8
x
|
3,29
x
|
1,98
x
|
1,33
x
|
1,2
x
|
Bedrijfswaarde/omzet
|
2,11
x
|
3,08
x
|
2,2
x
|
1,59
x
|
1,48
x
|
Bedrijfswaarde/EBITDA
|
15,2
x
|
55,3
x
|
20,4
x
|
16
x
|
11,2
x
|
Bedrijfswaarde/FCF
|
42,2
x
|
-11,7
x
|
-4,55
x
|
-28,9
x
|
-30,8
x
|
FCF Yield
|
2,37%
|
-8,55%
|
-22%
|
-3,46%
|
-3,25%
|
Price to Book
|
2,25
x
|
2,99
x
|
2,04
x
|
1,52
x
|
1,44
x
|
Aantal aandelen (in duizenden)
|
17.752
|
17.752
|
17.752
|
17.752
|
17.752
|
Referentieprijs
2 |
10.550
|
14.000
|
10.150
|
8.230
|
8.130
|
Datum van publicatie
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
66.938
|
75.603
|
90.968
|
109.729
|
120.535
|
EBITDA
1 |
9.257
|
4.212
|
9.841
|
10.918
|
15.876
|
Bedrijfsresultaat (EBIT)
1 |
7.624
|
2.317
|
7.772
|
8.396
|
10.457
|
Operationele Marge
|
11,39%
|
3,06%
|
8,54%
|
7,65%
|
8,68%
|
Resultaat voor belastingen (EBT)
1 |
7.324
|
1.502
|
8.134
|
9.353
|
8.249
|
Nettowinst (verlies)
1 |
5.699
|
1.529
|
6.703
|
8.001
|
6.748
|
Nettomarge
|
8,51%
|
2,02%
|
7,37%
|
7,29%
|
5,6%
|
WPA
2 |
400,5
|
86,14
|
377,6
|
450,7
|
380,1
|
Free Cash Flow
1 |
3.339
|
-19.936
|
-44.025
|
-6.062
|
-5.795
|
FCF-marge
|
4,99%
|
-26,37%
|
-48,4%
|
-5,52%
|
-4,81%
|
Kasstroomconversie (ebitda)
|
36,07%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
58,59%
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
20.101
|
28.891
|
34.098
|
Nettokaspositie
1 |
46.366
|
15.469
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
2,043
x
|
2,646
x
|
2,148
x
|
Free Cash Flow
1 |
3.339
|
-19.936
|
-44.025
|
-6.062
|
-5.795
|
ROE (netto-inkomsten/eigen vermogen)
|
10,2%
|
1,84%
|
7,82%
|
8,68%
|
6,87%
|
ROA (netto-inkomsten/totale activa)
|
6,54%
|
1,31%
|
3,83%
|
3,63%
|
4,26%
|
Totale activa
1 |
87.128
|
116.841
|
174.968
|
220.518
|
158.379
|
Nettoactief per aandeel
2 |
4.685
|
4.680
|
4.974
|
5.417
|
5.655
|
Cashflow per aandeel
2 |
688,0
|
1.331
|
494,0
|
149,0
|
90,30
|
Capex
1 |
1.121
|
22.328
|
42.874
|
7.447
|
941
|
Capex/omzet
|
1,67%
|
29,53%
|
47,13%
|
6,79%
|
0,78%
|
Datum van publicatie
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +17,59% | 126 mln. | | -3,05% | 90,45 mld. | | +3,95% | 41,45 mld. | | -10,51% | 33,57 mld. | | +60,58% | 25,73 mld. | | -20,09% | 14,73 mld. | | -8,92% | 12,82 mld. | | -11,46% | 11,7 mld. | | -43,05% | 11,44 mld. | | +5,17% | 8,79 mld. |
Biofarmaceutica
|